Organization · Accelerator
DayOne - Healthtech Innovation
DayOne - Healthtech Innovation is an accelerator based in Basel, Switzerland, focusing on early-stage healthtech ventures. It aims to transform healthcare through collaboration with global life science companies and research institutions.
Overview
What DayOne - Healthtech Innovation does
What DayOne - Healthtech Innovation is
DayOne - Healthtech Innovation is an accelerator based in Basel, Switzerland, focusing on early-stage healthtech ventures. It aims to transform healthcare through collaboration with global life science companies and research institutions.
How it participates in the startup ecosystem
The current public profile supports funder and program host capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Accelerator
- Structured capabilities
- Funder · Program host
- Last reviewed
- April 12, 2026
What Accelerator means
An accelerator is a structured, short-term program designed to speed up a startup's progress toward product-market fit, traction, fundraising, or scale.
Open the glossary entryOfficial channels
Find DayOne - Healthtech Innovation elsewhere
Open the official website or a supported primary organization account.
Capability profile
DayOne - Healthtech Innovation as a funder
Investment thesis
DayOne accelerates early-stage healthtech ventures addressing challenges in pharmaceutical R&D, fostering partnerships with pharmaceutical companies.
Focus narrative
DayOne invests in early-stage healthtech startups, particularly those at the intersection of healthtech and pharma R&D. The organization supports ventures from pre-seed to Series A stages, with a focus on companies that have raised less than $10 million in dilutive funds. DayOne aims to foster partnerships with pharmaceutical companies and enhance the startups' investor readiness.
Value beyond capital
DayOne provides mentorship, industry connections, and potential funding to healthtech startups, enhancing their investor readiness and fostering collaboration with pharmaceutical companies.
Terms and economics
- Typical check
- $0–$50,000
Focus and fit
- Stages
- Pre-seed · Seed · Series A
- Regions
- Europe
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 60
Portfolio context
DayOne has launched over 60 healthtech ventures since its inception. Notable portfolio companies include: Oncoustics: Utilizes AI to transform sound signals from low-cost ultrasound devices into virtual biopsy tools for democratizing diagnostics. FindMeCure / Trialhub: Provides insights that facilitate the transition from clinical trials to treatments. Theremia: An AI-driven platform that optimizes drug development for specific population subgroups. Risklick: Innovates clinical trial protocols using advanced AI software. Senseera Health: Focuses on transforming precision medicine and pioneering liver diagnostics through chromatin epigenomics.
Capability profile
DayOne - Healthtech Innovation as a program host
Program thesis
DayOne is a non-profit healthtech innovation organization focused on accelerating early-stage tech ventures that address challenges in pharmaceutical research and development.
Focus narrative
DayOne invests in early-stage healthtech startups, particularly those at the intersection of healthtech and pharma R&D. The organization supports ventures from pre-seed to Series A stages, with a focus on companies that have raised less than $10 million in dilutive funds. DayOne aims to foster partnerships with pharmaceutical companies and enhance the startups' investor readiness.
Value and support
DayOne offers a 3-month hybrid accelerator program providing mentorship, industry connections, and potential funding of up to CHF 50,000. Additionally, it has long-term support programs for promising startups, workspace, and operational support.
Additional public guidance
Q: What stages does DayOne support? A: DayOne supports startups from pre-seed to Series A stages. Q: How much funding can startups receive? A: Startups can receive potential funding of up to CHF 50,000. Q: Where is DayOne located? A: DayOne is based in Basel, Switzerland.
Terms and economics
- Indicative investment
- $50,000
Format and cadence
- Typical duration
- 12 weeks
- Format
- Hybrid
Availability
- Application state
- Accepting
Focus and fit
- Stages
- Pre-seed · Seed · Series A
- Sectors
- Healthcare
- Regions
- Europe
Alumni and track record
Alumni context
DayOne has launched over 60 healthtech ventures since its inception. Notable portfolio companies include Oncoustics, which utilizes AI to transform sound signals from low-cost ultrasound devices into virtual biopsy tools; FindMeCure / Trialhub, providing insights that facilitate the transition from clinical trials to treatments; Theria, an AI-driven platform optimizing drug development; Risklick, innovating clinical trial protocols using advanced AI software; and Senseera Health, focusing on precision medicine and liver diagnostics.
Common questions
What to know about DayOne - Healthtech Innovation
Upseed classifies DayOne - Healthtech Innovation under the Accelerator organization type. Its current public profile includes funder and program host capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 12, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.